The Immune System – News and Features

Researchers involved in the Influenza Genome Sequencing Project have sequenced the genomes of more than 2,000 influenza viruses.

The license, which augments XDx's strong proprietary position in this field, relates to the use of gene expression to assess the disease status of SLE patients.

Vitalea recieves NIAID grant to develop and test assays that can be applied to children and neonates to quantify intracellular uptake of antiretroviral drugs.

Both Companies in collaboration have developed a platform for customers in the diagnostics industry to test solutions based on Magnisense's MIAtek™ technology.

With three human RNAi gene therapy trials now under way, the technique may be among the first to find widespread use for treating human diseases.

Favrille reported data from a Phase II clinical trial of FavId® following high dose therapy and autologous stem cell transplantation in patients with non-Hodgkin's lymphoma.

Researchers have constructed a protein out of amino acids not found in natural proteins, discovering that they can form a complex, stable structure that closely resembles a natural protein.

Agilent will combine its analytical platforms with Lipomics’ expertise in biomarker discovery and validation to develop assays for metabolic diseases.

Scientists at Oakland Research Institute and University of Iowa have identified a gene variant that makes women more susceptible to developing heart disease.

Argos Therapeutics initiates a Phase 1/2 clinical trial to test the immunologic activity and safety of its AGS-004 in HIV-infected adults.